Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: Causes and implications

Human Reproduction

Volumn 11, Issue 6, 1996, Pages 1143-1144

  Kol, S ^a   Lewit, N ^a   Itskovitz Eldor, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADORELIN; TRIPTORELIN;

FEMALE; HUMAN; OVARY DISEASE; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; FERTILIZATION IN VITRO; METHODOLOGY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; REVIEW;

FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; TRIPTORELIN;

EID: 0030173098     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019339     Document Type: Short Survey

References (15)

1. Dubourdieu, S., Charbonnel, B., D'Acremont, M.F. et al. (1994) Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the peri-ovulatory period: the luteinizing hormone surge requires secretion of GnRH. J. Clin. Endocrinol. Metab., 78, 343-347.
2. Emperaire, J.C. and Ruffie, A. (1991) Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum. Reprod., 6, 506-510.
3. Gerris, J., De Vits, A., Joostens, M. and Van Royen, E. (1995) Triggering of ovulation in human menopausal gonadotropin-stimulated cycles: comparison between intravenous administered gonadotrophin-releasing hormone (100 and 500 μg), GnRH agonist (buserelin, 500 μg) and human chorionic gonadotrophin (10000 IU). Hum. Reprod., 10, 56-62.
4. Imoedemhe, D.A.G., Chan, R.C.W., Sigue, A.B. et al. (1991) A new approach to the management of patients at risk of ovarian hyperstimulation in an invitro fertilization programme. Hum. Reprod., 6, 1088-1091.
5. Itskovitz, J., Boldes, R., Barlev, A. et al. (1988) The induction of LH surge and oocyte maturization by GnRH analogue (buserelin) in women undergoing ovarian stimulation for in vitro fertilization. Gynecol. Endocrinol., 2 (Suppl. 2), 165.
6. Itskovitz, J., Boldes, R., Levron, J. et al. (1991) Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril., 56, 213-220.
7. Itskovitz-Eldor, J., Levron, J. and Kol, S. (1993) Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome. Clin. Obstet. Gynecol., 36, 701-710.
8. Lanzone, A., Fulghesu, A.M., Villa, P. et al. (1994) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertil. Steril., 62, 35-41.
9. Lewit, N., Kol, S., Manor, D. and Itskovitz-Eldor, J. (1995) The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome. Gynecol. Endocrinol., (Suppl. 4), 13-17.
10. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
11. Segal, S. and Casper, R.F. (1992) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril., 57, 1254-1258.
12. Shalev, E., Geslevich, Y. and Ben-Ami, M. (1994) Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at high risk for developing the ovarian hyperstimulation syndrome. Hum. Reprod., 9, 417-419.
13. Shalev, E., Geslevich, Y., Matilsky, M. and Ben-Ami, M. (1995) Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulalory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles. Hum. Reprod., 10, 2244-2247.
14. Shoham, Z., Schachter, M., Loumaye, E. et al. (1995) The luteinizing hormone surge-the final stage in ovulation induction: modern aspects of ovulation triggering. Fertil. Steril., 64, 237-251.
15. van der Meer, S., Gerris, J., Joostens, M. and Tas, B. (1993) Triggering of ovulation using a gonadotropin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1628-1631.